Advertisement

Skin autofluorescence as a tool for cardiovascular risk estimation in patients with rheumatoid arthritis

      Highlights

      • SCORE with age adjustment overestimates cardiovascular risk in RA patients.
      • SAF measurement yields similar results compared to the SCORE without age adjustment.
      • SCORE with no age adjustment combined with SAF might be the best strategy for RA.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aviña-Zubieta J.A.
        • Choi H.K.
        • Sadatsafavi M.
        • Etminan M.
        • Esdaile J.M.
        • Lacaille D.
        Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.
        Arthritis Rheum. 2008; 59: 1690-1697
        • Crowson C.S.
        • Rollefstad S.
        • Ikdahl E.
        • Kitas G.D.
        • van Riel P.L.C.M.
        • Gabriel S.E.
        • et al.
        On behalf of a trans-Atlantic cardiovascular consortium for rheumatoid arthritis (ATACC-RA). Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.
        Ann Rheum Dis. 2018; 77: 48-54https://doi.org/10.1136/annrheumdis-2017-211735
        • Dixon W.G.
        • Watson K.D.
        • Lunt M.
        • Dixon W.G.
        • Watson K.D.
        • Lunt M.
        • et al.
        British Society for Rheumatology Biologics Register Control Centre Consortium, British Society for Rheumatology Biologics Register. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology biologics register.
        Arthritis Rheum. 2007; 56: 2905-2912
        • Quality Institute for Health (CBO)
        Dutch General Practitioner society (NHG) Multidisciplinary guideline on cardiovascular risk management.
        • Perk J.
        • De Backer G.
        • Gohlke H.
        • Graham I.
        • Reiner Z.
        • Verschuren M.
        • et al.
        European guidelines on CVD practices in clinical practice (2012).
        Eur Heart. 2012; 33: 1635-1701
        • Meerwaldt R.
        • Graaff R.
        • Oomen P.H.
        • Links T.P.
        • Jager J.J.
        • Alderson N.L.
        • et al.
        Simple non-invasive assessment of advanced glycation endproduct accumulation.
        Diabetologia. 2004; 47: 1324-1330
        • Waateringe van R.P.
        • Slagter S.N.
        • Beek van A.P.
        • van der Klauw M.M.
        • van Vliet-Ostaptchouk J.V.
        • Graaff R.
        • et al.
        Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.
        Diabetol Metab Syndr. 2017; 9: 42
        • Waateringe van R.P.
        • Fokkens B.T.
        • Slagter S.N.
        • van der Klauw M.M.
        • van Vliet-Ostaptchouk J.V.
        • Graaff R.
        • et al.
        Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.
        Diabetologia. 2019 Feb; 62 ([Epub 2018 Nov]): 269-280https://doi.org/10.1007/s00125-018-4769-x